pillbase.ru

ADVAIR DISKUS

Active substance: SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE

POWDER · SALMETEROL XINAFOATE 50 ug/1, FLUTICASONE PROPIONATE 250 ug/1

United StatesActive

Marketing holder: GlaxoSmithKline LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing salmeterol xinafoate in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
EU 3
  • Seffalair Spiromax
    fluticasone propionate, salmeterol xinafoate
    EMEA/H/C/004881
    Teva B.V.
  • Aerivio Spiromax
    salmeterol xinafoate, fluticasone propionate
    EMEA/H/C/002752
    Teva B.V.
  • BroPair Spiromax
    salmeterol xinafoate, fluticasone propionate
    EMEA/H/C/005591
    Teva B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-1b7c-7066-8cfa-96a00dba453f;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0173-0696
Registration status
Active
Dispensing
Prescription only
Route
RESPIRATORY (INHALATION)
Sources
  • product · openFDA NDC · 0173-0696 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0173-0696 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0173-0696 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 0173-0696 · Verified 2026-10-09 · open in source